202208 bckwRGCOthersOthers: General Research Fund (15205119);Shenzhen Science and Technology Innovation Commission (JCYJ20190809153201668);Sanming Project of Medicine in Shenzhen (SZSM201603029
A prospective study was conducted among 100 patients selected from amongst those who were registered...
Background: Antituberculosis (ATT) drug-induced liver injury (DILI) is a common and serious adverse ...
To systematically evaluate the incidence of liver injury in multi-drug resistant tuberculosis (MDR-T...
ObjectiveTo investigate the clinical features of liver injury induced by anti-tuberculosis drugs and...
Objectives: To identify the risk factors associated with anti-tuberculosis drug-induced liver injury...
<p><strong>Introduction and objectives:</strong></p><p>Tuberculosis (TB) still remains a major healt...
Background: The use of anti-tuberculosis drugs (ATD) is not uncommon to find side effects that compl...
Antitubercular drugs cause derangement of hepatic functions revealed by clinical examination and abn...
Objectives: The aim of this research study is to diagnose various factors of risks of ATDH (Anti-TB ...
Objectives: The aim of this research study is to diagnose various factors of risks of ATDH (Anti-TB ...
Objective: We aimed to assess and evaluate the anti-tubercular agents (ATT) induced hepatitis among ...
Aims: To find out the frequency of hepatotoxicity in recipients of the anti-tubercular drugs, predic...
Objective To analyze the clinical and laboratory features and determine the predictors of acute live...
Anti-tuberculosis drug induced liver injury (ATLI) is emerging as a significant threat to tuberculos...
Objective: Identification of risk factors associated with anti-tuberculosis drug-induced hepatotoxic...
A prospective study was conducted among 100 patients selected from amongst those who were registered...
Background: Antituberculosis (ATT) drug-induced liver injury (DILI) is a common and serious adverse ...
To systematically evaluate the incidence of liver injury in multi-drug resistant tuberculosis (MDR-T...
ObjectiveTo investigate the clinical features of liver injury induced by anti-tuberculosis drugs and...
Objectives: To identify the risk factors associated with anti-tuberculosis drug-induced liver injury...
<p><strong>Introduction and objectives:</strong></p><p>Tuberculosis (TB) still remains a major healt...
Background: The use of anti-tuberculosis drugs (ATD) is not uncommon to find side effects that compl...
Antitubercular drugs cause derangement of hepatic functions revealed by clinical examination and abn...
Objectives: The aim of this research study is to diagnose various factors of risks of ATDH (Anti-TB ...
Objectives: The aim of this research study is to diagnose various factors of risks of ATDH (Anti-TB ...
Objective: We aimed to assess and evaluate the anti-tubercular agents (ATT) induced hepatitis among ...
Aims: To find out the frequency of hepatotoxicity in recipients of the anti-tubercular drugs, predic...
Objective To analyze the clinical and laboratory features and determine the predictors of acute live...
Anti-tuberculosis drug induced liver injury (ATLI) is emerging as a significant threat to tuberculos...
Objective: Identification of risk factors associated with anti-tuberculosis drug-induced hepatotoxic...
A prospective study was conducted among 100 patients selected from amongst those who were registered...
Background: Antituberculosis (ATT) drug-induced liver injury (DILI) is a common and serious adverse ...
To systematically evaluate the incidence of liver injury in multi-drug resistant tuberculosis (MDR-T...